<DOC>
	<DOCNO>NCT01591798</DOCNO>
	<brief_summary>After introduce minimally invasive surgery , robotic surgery increasingly use colorectal cancer . However , prospective study robotic surgery . The aim trial evaluate effectiveness safety robotic surgery mid low rectal cancer .</brief_summary>
	<brief_title>Efficacy Study Robotic Surgery Rectal Cancer</brief_title>
	<detailed_description>This study design randomize phase II trial ( laparoscopic versus robotic ) . The primary end point quality mesorectal excision .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>mid low rectal cancer ( within 9cm anal verge ) pathologically proven adenocarcinoma write informed consent severe functional disability lung heart invade adjacent organ distant metastasis ( lung , liver , brain , bone , distant lymph node etc . ) lateral pelvic lymph node metastasis Have severe concomitant disease might limit compliance completion protocol . Have malignancy might impact 5year survival might potentially confused rectal cancer . If female , pregnant breast feeding . Hereditary colorectal cancer ( HNPCC , FAP etc ) emergency operation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Rectal cancer</keyword>
	<keyword>Robotic surgery</keyword>
	<keyword>Laparoscopic surgery</keyword>
</DOC>